SARTORIUS AG VZO O.N. news, videos and press releases
For more news please use our advanced search feature.
SARTORIUS AG VZO O.N. - More news...
SARTORIUS AG VZO O.N. - More news...
- EQS-News: Sartorius to acquire microtissue business MatTek from Swedish BICO AB
- EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius
- EQS-News: Sartorius AG - Resolutions of the Annual General Meeting
- EQS-News: Sartorius releases Annual Report for 2024
- EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
- EQS-News: Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved
- EQS-News: Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG
- EQS-Adhoc: SARTORIUS AG: Michael Grosse to become Chief Executive Officer of Sartorius AG
- EQS-News: Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
- EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
- EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
- Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
- Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
- Sartorius with clear double-digit growth in fiscal 2022
- Sartorius with continued growth in a challenging environment
- Sartorius to acquire Albumedix, creating a powerhouse for innovative advanced therapy solutions
- Sartorius Annual General Shareholders' Meeting: Focus on innovation, growth and sustainability
- Sartorius presents annual report for 2021
- The Supervisory Board of Sartorius AG proposes dividend of 1.26 euros per preference share
- Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability
- Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions
- Sartorius grows operations in France and is investing 100 million euros by 2025
- Sartorius significantly expands activities in South Korea
- Sartorius grows dynamically and profitably - Substantial double-digit increases in sales and earnings
- Change in Composition of Sartorius Joint Heirship
- Sartorius to expand Business Operations in North America
- Sartorius to Open New Application and Service Hub in Shanghai
- Sartorius To Join The DAX Blue Chip Index
- Sartorius acquires cell culture specialist Xell AG
- Sartorius continues on its fast growth trajectory - significant double-digit increases in sales and earnings
